Michaela Nováková

1.6k total citations
35 papers, 556 citations indexed

About

Michaela Nováková is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Michaela Nováková has authored 35 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 9 papers in Public Health, Environmental and Occupational Health and 8 papers in Genetics. Recurrent topics in Michaela Nováková's work include Acute Lymphoblastic Leukemia research (9 papers), Acute Myeloid Leukemia Research (7 papers) and Lymphoma Diagnosis and Treatment (6 papers). Michaela Nováková is often cited by papers focused on Acute Lymphoblastic Leukemia research (9 papers), Acute Myeloid Leukemia Research (7 papers) and Lymphoma Diagnosis and Treatment (6 papers). Michaela Nováková collaborates with scholars based in Czechia, Germany and Netherlands. Michaela Nováková's co-authors include Gad Frankel, Gordon Dougan, D. C. A. Candy, Alan D. Phillips, Ester Mejstříková, David B. Schauer, Hugh J. Field, Gill Douce, Jacques J. M. van Dongen and Jeannette Adu‐Bobie and has published in prestigious journals such as Blood, PLoS ONE and Molecular Microbiology.

In The Last Decade

Michaela Nováková

34 papers receiving 547 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michaela Nováková Czechia 14 193 170 138 131 126 35 556
Vineeth Varanasi India 6 71 0.4× 129 0.8× 22 0.2× 40 0.3× 54 0.4× 10 388
Keiji Okinaka Japan 13 39 0.2× 73 0.4× 191 1.4× 144 1.1× 46 0.4× 43 516
Guylaine Lépine Canada 13 20 0.1× 127 0.7× 195 1.4× 291 2.2× 142 1.1× 23 803
Rory Care United Kingdom 10 28 0.1× 206 1.2× 497 3.6× 459 3.5× 101 0.8× 14 1.2k
Praveen Sharma India 10 29 0.2× 46 0.3× 91 0.7× 55 0.4× 48 0.4× 58 305
Renan Aguilar‐Valenzuela United States 7 98 0.5× 58 0.3× 56 0.4× 85 0.6× 12 0.1× 12 373
Anwari Akhter United States 14 245 1.3× 66 0.4× 29 0.2× 626 4.8× 48 0.4× 20 1.0k
Renée M. Laird United States 14 77 0.4× 108 0.6× 13 0.1× 122 0.9× 17 0.1× 31 522
Kaiyu Wu Canada 9 41 0.2× 185 1.1× 35 0.3× 350 2.7× 56 0.4× 13 1.1k
R D Sublett United States 8 66 0.3× 29 0.2× 136 1.0× 147 1.1× 16 0.1× 8 513

Countries citing papers authored by Michaela Nováková

Since Specialization
Citations

This map shows the geographic impact of Michaela Nováková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michaela Nováková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michaela Nováková more than expected).

Fields of papers citing papers by Michaela Nováková

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michaela Nováková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michaela Nováková. The network helps show where Michaela Nováková may publish in the future.

Co-authorship network of co-authors of Michaela Nováková

This figure shows the co-authorship network connecting the top 25 collaborators of Michaela Nováková. A scholar is included among the top collaborators of Michaela Nováková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michaela Nováková. Michaela Nováková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Coufal, Štěpán, Miloslav Kverka, Jakub Kreisinger, et al.. (2023). Serum TGF-β1 and CD14 Predicts Response to Anti-TNF-α Therapy in IBD. Journal of Immunology Research. 2023. 1–16. 3 indexed citations
2.
Maurer‐Granofszky, Margarita, Michael J. Reiter, Angela Schumich, et al.. (2023). FCM marker importance for MRD assessment in T‐cell acute lymphoblastic leukemia: An AIEOP‐BFM‐ALL‐FLOW study group report. Cytometry Part A. 105(1). 24–35. 6 indexed citations
3.
Rob, Filip, Martin Kolář, Jakub Kreisinger, et al.. (2023). Skin microbiota signature distinguishes IBD patients and reflects skin adverse events during anti-TNF therapy. Frontiers in Cellular and Infection Microbiology. 12. 1064537–1064537. 6 indexed citations
4.
Nováková, Michaela, Markéta Žaliová, Eva Froňková, et al.. (2022). CD38: A target in relapsed/refractory acute lymphoblastic leukemia—Limitations in treatment and diagnostics. Pediatric Blood & Cancer. 69(9). e29779–e29779. 4 indexed citations
5.
Matarraz, Sergio, Stefan Nierkens, Michaela Nováková, et al.. (2022). Immunophenotypic Analysis of Acute Megakaryoblastic Leukemia: A EuroFlow Study. Cancers. 14(6). 1583–1583. 12 indexed citations
6.
Rob, Filip, Zuzana Stehlíková, Jakub Kreisinger, et al.. (2022). Association between ustekinumab therapy and changes in specific anti-microbial response, serum biomarkers, and microbiota composition in patients with IBD: A pilot study. PLoS ONE. 17(12). e0277576–e0277576. 4 indexed citations
7.
Nytrová, Petra, Michaela Nováková, Jiří Beneš, et al.. (2022). SARS-CoV-2 Specific Humoral Immune Responses after BNT162b2 Vaccination in Hospital Healthcare Workers. Vaccines. 10(12). 2038–2038. 4 indexed citations
8.
Roubalová, Radka, Martin Kolář, Zuzana Stehlíková, et al.. (2021). Fecal Microbiome Changes and Specific Anti-Bacterial Response in Patients with IBD during Anti-TNF Therapy. Cells. 10(11). 3188–3188. 21 indexed citations
9.
Böttcher, Sebastian, Robby Engelmann, Georgiana Grigore, et al.. (2021). Expert-independent classification of mature B-cell neoplasms using standardized flow cytometry: a multicentric study. Blood Advances. 6(3). 976–992. 14 indexed citations
10.
Nováková, Michaela, Markéta Žaliová, Karel Fišer, et al.. (2020). <i>DUX4r</i>, <i>ZNF384r</i> and <i>PAX5</i>-P80R mutated B-cell precursor acute lymphoblastic leukemia frequently undergo monocytic switch. Haematologica. 106(8). 2066–2075. 32 indexed citations
11.
12.
Nováková, Michaela, Alena Musilová, Monika Brüggemann, et al.. (2018). Switching Towards Monocytic Lineage and Discordancy between Flow Cytometric and PCR Minimal Residual Disease Results Is a Hallmark Feature of DUX4 Rearranged B-Cell Precursor Acute Lymphoblastic Leukemia. Blood. 132(Supplement 1). 2825–2825. 2 indexed citations
13.
Sędek, Łukasz, Prisca Theunissen, Elaine Sobral da Costa, et al.. (2018). Differential expression of CD73, CD86 and CD304 in normal vs. leukemic B-cell precursors and their utility as stable minimal residual disease markers in childhood B-cell precursor acute lymphoblastic leukemia. Journal of Immunological Methods. 475. 112429–112429. 42 indexed citations
14.
Theunissen, Prisca, Łukasz Sędek, Válerie de Haas, et al.. (2017). Detailed immunophenotyping of B‐cell precursors in regenerating bone marrow of acute lymphoblastic leukaemia patients: implications for minimal residual disease detection. British Journal of Haematology. 178(2). 257–266. 25 indexed citations
15.
Froňková, Eva, Adam Klocperk, Michael Svatoň, et al.. (2014). The TREC/KREC Assay for the Diagnosis and Monitoring of Patients with DiGeorge Syndrome. PLoS ONE. 9(12). e114514–e114514. 24 indexed citations
16.
Heuvel‐Eibrink, Marry M. van den, Irith Baumann, Michael Dworzak, et al.. (2014). Bone marrow immunophenotyping by flow cytometry in refractory cytopenia of childhood. Haematologica. 100(3). 315–323. 27 indexed citations
17.
Čechová, D., Michaela Nováková, Karel Mikulı́k, et al.. (2012). Immunomodulatory properties of subcellular fractions of a G+ bacterium, Bacillus firmus. Folia Microbiologica. 58(2). 111–121. 1 indexed citations
18.
Halaška, M, et al.. (2007). [Detection of postoperative lymphoedema in patients with breast cancer].. PubMed. 72(4). 299–304. 2 indexed citations
19.
Frankel, Gad, Alan Philips, Michaela Nováková, et al.. (1998). Generation of Escherichia coli intimin derivatives with differing biological activities using site‐directed mutagenesis of the intimin C‐terminus domain. Molecular Microbiology. 29(2). 559–570. 50 indexed citations
20.
Nováková, Michaela, et al.. (1967). [Psychological aspects in the complex care of children with hemophilia].. PubMed. 22(9). 800–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vineeth Varanasi Breakdown of academic impact, for papers by Keiji Okinaka Breakdown of academic impact, for papers by Guylaine Lépine Breakdown of academic impact, for papers by Rory Care Breakdown of academic impact, for papers by Praveen Sharma Breakdown of academic impact, for papers by Renan Aguilar‐Valenzuela Breakdown of academic impact, for papers by Anwari Akhter Breakdown of academic impact, for papers by Renée M. Laird Breakdown of academic impact, for papers by Kaiyu Wu Breakdown of academic impact, for papers by R D Sublett
Rankless by CCL
2026